lyzalon pregabalin 75 mg capsules blister pack
accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: titanium dioxide; purified water; gelatin; purified talc; pregelatinised maize starch; iron oxide red; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
lyzalon pregabalin 75 mg capsules bottle pack
accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; iron oxide red; gelatin; titanium dioxide; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
lyzalon pregabalin 150 mg capsules blister pack
accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: purified talc; titanium dioxide; gelatin; purified water; sodium lauryl sulfate; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
lyzalon pregabalin 300 mg capsules blister pack
accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; pregelatinised maize starch; titanium dioxide; iron oxide red; purified talc; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
lyzalon pregabalin 25 mg capsules bottle pack
accord healthcare pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; pregelatinised maize starch; purified water; titanium dioxide; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
drogenil 250 milligram tablets
merck sharp & dohme ireland (human health) limited - flutamide - tablets - 250 milligram - anti-androgens
oki mouth wash
dompe farmaceutici spa via san martino 12, 20122, milan, italy - ketoprofen lysine - oromucosal solution - ketoprofen lysine 1.6 % (w/v) - stomatological preparations
psoriderm solution for topical use
birzeit pharmaceutical company (bpc) - clobetasol (clobetasol propionate) - solution for topical use - 0,5mg/ml
cochlear nucleus 5 system
cochlear limited - ear, nose & throat - to provide auditory sensation and sound perception by electrically stimulating the auditory nerve. indications: a. individuals aged 12mth to 17yrs with clinically established bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. b. individuals aged 18yrs and older with clinically established postlinguistic bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. c. prelinguistically or perilinguistically deafened individuals aged 18yrs and older who have profound bilateral sensorineural hearing loss and compromised hearing with hearing aids.
cochlear nucleus ci422 cochlear implant with straight electrode
cochlear limited - ear, nose & throat - to provide auditory sensation and sound perception by electrically stimulating the auditory nerve. indications: a. individuals aged 12mth to 17yrs with clinically established bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. b. individuals aged 18yrs and older with clinically established postlinguistic bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. c. prelinguistically or perilinguistically deafened individuals aged 18yrs and older who have profound bilateral sensorineural hearing loss and compromised hearing with hearing aids.